Rockwell Medical (RMTI) Shares Outstanding (Diluted Average) (2020 - 2026)
Rockwell Medical filings provide 6 years of Shares Outstanding (Diluted Average) readings, the most recent being $36.0 million for Q4 2025.
- On a quarterly basis, Shares Outstanding (Diluted Average) rose 15.83% to $36.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.0 million, a 15.83% increase, with the full-year FY2025 number at $36.0 million, up 15.83% from a year prior.
- Shares Outstanding (Diluted Average) hit $36.0 million in Q4 2025 for Rockwell Medical, up from $34.8 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $36.0 million in Q4 2025 to a low of $8.5 million in Q1 2021.
- Median Shares Outstanding (Diluted Average) over the past 5 years was $20.0 million (2023), compared with a mean of $21.4 million.
- Biggest five-year swings in Shares Outstanding (Diluted Average): tumbled 88.73% in 2021 and later soared 116.69% in 2022.
- Rockwell Medical's Shares Outstanding (Diluted Average) stood at $8.5 million in 2021, then surged by 67.77% to $14.3 million in 2022, then soared by 63.05% to $23.3 million in 2023, then soared by 33.17% to $31.1 million in 2024, then rose by 15.83% to $36.0 million in 2025.
- The last three reported values for Shares Outstanding (Diluted Average) were $36.0 million (Q4 2025), $34.8 million (Q3 2025), and $34.3 million (Q2 2025) per Business Quant data.